Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C

Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C
复制标题

DOI:
10.1007/s535-002-8130-z
复制
发表时间:
2002-01-01
影响因子:
6.3
通讯作者:
Kumada, H
Kumada, H
中科院分区:
医学1区
文献类型:
--
作者:
Kobayashi, M;Arase, Y;Kumada, H

文献摘要

被引文献

相似文献

背景本研究的目的是根据B肝炎病毒(HBV)的基因型,在东京都慢性肝病和B肝炎表面抗原(HBsAg)阳性患者的首次医院咨询的临床特征进行评估。方法.受试者包括1077例HBeAg阳性的慢性肝病患者。HBV基因型通过酶联免疫吸附试验(ELISA)确定,使用PreS2单克隆抗体,这是特异性的HBV基因型在PreS2区域。结果基因型A的患者比例为21a(20例患者),基因型B 9%(101例患者),基因型C 88%(945例患者),而11例患者(1.0%)有其他基因型,包括基因型D和F各2例(0.2%),7例(0.6%)无法分型。与基因型B的患者相比,基因型A的患者在第一次咨询时更容易出现B型肝炎包膜抗原(HBeAg)阳性(P = 0.049)。基因型B的患者与基因型A(P = 0.049)和基因型C(P = 0.001)的患者相比,首次就诊时HBeAg阴性的可能性更大,出现轻微肝纤维化的可能性更大(P = 0.003),发生肝硬化的可能性最小(P = 0.005)。C基因型患者可能是HBeAg阳性(P = 0.001),并有HBV感染的阳性家族史(P = 0.0002)。结论.东京大都市HBV感染患者的临床特征因HBV基因型而异。
Background The aim of the present study was to evaluate the clinical characteristics at first hospital consultation, according to the genotype of hepatitis B virus (HBV), in patients with chronic liver diseases and positivity for hepatitis B surface antigen (HBsAg) in metropolitan Tokyo. Methods. The subjects consisted of 1077 patients with chronic liver diseases who were HBsAg-positive. HBV genotype was determined by an enzyme-linked immunosorbent assay (ELISA), using PreS2 monoclonal antibody, which is specific for HBV genotypes in the PreS2 region. Results. The proportion of patients with genotype A was 2 la (20 patients), genotype, B 9% (101 patients), and genotype C, 88% (945 patients), while 11 patients (1.0%) had other genotypes, including 2 (0.2%) each with genotypes D and F, and 7 (0.6%) that were untypeable. Patients with genotype A were significantly (P = 0.049) more likely to be positive for Hepatitis B envelope antigen (HBeAg) at the first consultation compared with those with genotype B. Patients with genotype B were significantly more likely to be HBeAg-negative at the first consultation compared with those with genotype A (P = 0.049) and genotype C (P = 0.001), significantly more likely to show minimal hepatic fibrosis (P = 0.003), and least likely to develop liver cirrhosis (P = 0.005). Patients with genotype C were likely to be HBeAg-positive (P = 0.001) and to have a positive family history of HBV infection (P = 0.0002). Conclusions. The clinical features of patients with HBV infection in metropolitan Tokyo varied depending on the HBV genotype.